Eurogin 2003 - Paris 13-16 April 2003

SCIENTIFIC PROGRAMME

Sunday 13 April I Monday 14 April I Tuesday 15 April I Wednesday 16 April I

Sunday 13 April 2003
Training Courses

	*For clinicians, pre-congress courses aim to provide educational strategies, enablig acquisition of skills and an update of expertise in line with the aims of Continuing Medical Education. This should allow participants to integrate into their clinical practice, the terminology, basic and advanced principles of instrumentation, normal and abnormal colposcopic patterns as well as diagnosis and management of cervical and vulvar diseases. For pathologists and virologists*, the course comprises a comprehensive introduction to cervical cytopathology, terminology, laboratory quality standards, normal and abnormal patterns of cervical cytology with both conventional smears and liquid based cytology. Case studies of cyto-histological correlations and HPV-testing applications will be presented. Enrolment in these sessions is limited in order to facilitate optimal interaction between faculty and attendees ; kindly pre-register to attend these sessions Registration on line



TC1 COMPREHENSIVE COLPOSCOPY COURSE
TC1-1 DIAGNOSIS OF CIN
	Chairs : S. Dexeus (Spain), B. Blanc (France), A. Singer (UK) • Educational lecture H. Jones (USA) • Colposcopy of the normal cervix A. Singer (UK) • Grading colposcopic features S. Dexeus (Spain) • Colposcopy of the abnormal cervix (CIN and HPV infections) P. Walker (UK) • Colposcopy of glandular lesions J. Jordan (UK) • Discussion
TC1-2 TREATMENT OF CIN
	Chairs : G. de Palo (Italy), J.C. Boulanger (France) • How to treat? W. Prendiville (Ireland) • Results - Complications- Follow-up D. Luesley (UK)
TC1-3 INTERACTIVE COURSE: VIDEO MASTER CLASS AND CASE STUDIES (TOUCH PAD)
	Chairs : M. Roy (Canada), J.L. Leroy (France), A. Singer (UK)
With the contribution of the experts: A. Singer (UK), J.L. Leroy (France), D. Luesley (UK), A. Ferenczy (Canada), F. Boselli (Italie), A. Perino (Italie), J.C. Boulanger (France), J.L. Mergui (France), T.J.M. Helmerhost (), D. Pereira da Silva (Portugal), J.A. Moutinho (Portugal), M. Menton (Germany), E. Diakomanolis (Greece), S.A. Tatti (Argentina), P. Naud (Brazil), S. Dexeus (Spain), A. Bar-Am (Israel), J. Jordan (UK), R. Testa (Argentina), P. Walker (UK), G. De Palo (Italy), M. Peroni (Italy), H. Jones (USA), B. Blanc (France)


TC2 CYTOPATHOLOGY COURSE
	Chairs : E. Mc Googan (UK), M. Austin (USA), M. Sherman (USA), A. Verhest (Belgium) • Educational lecture E. Wilkinson (USA) • Basic issues and terminology M. Sherman (USA) • Liquid-based cytology M. Austin (USA) • Computer-assisted automation *D. Wilbur (France)* • Proliferation and differentiation markers E. Mc Googan (UK) • Molecular techniques for cytodiagnosis J. Linder (USA)
INTERACTIVE CASE STUDIES
With the contribution of the experts: R. Ashfaq (USA), R. Dachez (France), S. Labbe (France), N. Froment (France), R. Marty (France), L. Zerat (France), J. Linder (USA), F. Montz (USA), O. Real (Portugal), A. Meisels (Canada), J.C. Hammou (France), H. Koutsellini (Greece), J. Linder (USA), D. Wilbur (USA).


TC3 VULVAR DISEASES COURSES
TC3-1 VULVAR PATHOLOGY COURSE
	Chairs: M. Faure (France), M. Roy (Canada), M. Sideri (Italy) • Educational lecture R. W. Jones (New Zealand) • The vulva: from normal to disease M. Moyal-Barracco (France) • Lichen sclerosus and vulvar hyperplasia S. Neill (UK) • Lichen erosive of the vulva M. Pelisse (France) • Ulceration of the vulva M. Faure (France) • VIN, diagnosis and treatment M. Sideri (Italy) • Paget’s disease B. Paniel (France) • Vulvodynia J. Bornstein (Israel) • Psychosomatic evaluation of vulvar pain M. Steben (Canada)
INTERACTIVE CASE STUDIES (TOUCH PAD)
	Chairs: M. Roy (Canada), L. Micheletti (Italy), M. Pelisse (France) With the contribution of the experts: Van Beurden (The Netherlands), M. Faure (France), M. Pelisse (France), L. Micheletti (Italy), J. Bornstein (Israel), R. W. Jones (New Zealand), M. Sideri (Italy), M. Friedman (Israel), M. Moyal-Barracco (France).



TC4 OFFICE GYNAECOLOGICAL PROCEDURES
TC4-1 LOWER GENITAL TRACT
	Chairs : A. Ferenczy (Canada), L. Pardal (Portugal) • Digital colposcopy Q.S. Chong (Indonesia) • EEC biopsy versus endocervical brusching A. Ferenczy (Canada) • Indications and modalities of CO2 laser A. Singer (UK) • LLETZ, SWETZ W. Prendiville (Ireland) • Variloop A. Mergui (France) • Cryotherapy A. Ferenczy (Canada) • Treatment of vaginal disease E. Paraskevaidis (Greece)
TC4-2 BREAST
	Ductal lavage and the management of women at high risk of breast cancer V. Vogel (USA)
TC1-3 ENDOMETRIUM
	Chairs : W. Prendiville (Ireland), E. Paraskevaidis (Greece) • Hysterosonography versus hysteroscopy N. Perrot (France) • 3D ultrasound versus 2D vaginal scanning for uterine diseases F. Bonnilla-Musoles (Spain) • Adnexal diseases: the suspicious signs J.N. Buy (France) • Management of post-menopausal bleeding L. Boubli (France) • Hysteroscopic treatment of synechias L. Montevecchi (Italy) • Office hysteroscopy: is it possible during consultation? J.L. Mergui (France)



SEMINARS
	The purpose of these seminars is to provide recommendations for improved clinical practice based on collective expertise. Appointed experts will be at work and their conclusions will be presented during a plenary session.The written conclusions will be available during the congress. Observers are welcome at these sessions on the strict proviso that advance registration is made by completing and returning Form D. These sessions are open to everyone involved in organising cervical cancer screening programmes. The aims are : • to initiate dialogue and to provide the opportunity for exchanging experiences • to assess the medical and economic advantages of the programmes • to discuss the feasibility of rational approaches to optimising both cytological management of the disease and quality assurance, taking into consideration the role of recent technology and economic necessities. Registration on line
SEM1 HPV IN CLINICAL PRACTICE
SEM1-1 ROLE OF HPV TESTING FOR MANAGING PATIENTS WITH ABNORMAL PAP
	Chairs : T. Cox (USA), C. Meijer (The Netherlands) • Epidemiological evidence and rationale for HPV testing E. Franco (Canada) • Novel markers for risk stratification of HPV positive women A. Lorincz (USA) • Revue of current practice W. Kinney (USA) • Management as a result of ALTS trial and Bethesda protocols T. Cox (USA) • HPV as a test of cure T. Wright (USA) • Discussion
HPV TESTING IN PRIMARY SCREENING, AN INTERNATIONAL EXPERIENCE SEM1-2 Developed countries
	Chairs : T. Cox (USA), C. Meijer (The Netherlands) • United Kingdom: the HART study update J. Cuzick (UK) • France C. Clavel (France) • Germany T. Iftner (Germany) • Netherlands C. Meijer (NL) • Canada S. Ratnam (Canada) • Portland study update A. Lorincz (USA) • Discussion
SEM1-3 Developing countries
	Chairs : T. Cox (USA), C. Meijer (The Netherlands) • South Africa L. Denny (South Africa) • India R. Sankaranarayanan (France) • China J.L. Belinson (USA) • Conclusions T. Cox (USA), C. Meijer (The Netherlands)

SEM2 EMERGING ISSUES IN CERVICAL CANCER SCREENING
SEM2-1 Developed countries
	Chairs: F. Montz (USA), M. Parkin (France), J. Patnick (UK) • Epidemiology of cervix cancer in developed countries. Evolution since the introduction of the PAP test M. Parkin (France) • Screening programs for cervical cancer M. Shier (Canada), J. Patnick (UK), H. Mitchell (Australia) • Challenge for the future F. Montz (USA) • Economics: efficacy, cost-effectiveness and limiting factors *D. Habbema (Netherlands)* • General Discussion
SEM2-2 Developing countries
	Chairs: R. Sankaranarayanan (F), L. Denny (South Africa), H. Mitchell (Australia) • Cytology L. Denny (South Africa) • HPV testing T. Wright (USA) • VIA R. Sankaranarayanan (F) • Real time screening methods A. Singer (UK) • Screening methods relevant to developing countries T. Wright (USA) • Discussion

Congress Secretariat
VBCE – EUROGIN – C. Cabotin
33, rue de l’Abbé Groult, 75015 Paris - France
Tel. +33 (0)1 45 33 60 46
Fax +33 (0)1 45 33 57 15

Scientific Secretariat
EUROGIN
174, rue de Courcelles, 75017 Paris -France
Tel. +33 (0)1 44 40 01 20
Fax +33 (0)1 47 66 74 70
admin@eurogin.com